Hans‐Georg Lerchen

660 total citations
33 papers, 433 citations indexed

About

Hans‐Georg Lerchen is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hans‐Georg Lerchen has authored 33 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Organic Chemistry. Recurrent topics in Hans‐Georg Lerchen's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Chemical Synthesis and Analysis (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Hans‐Georg Lerchen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Chemical Synthesis and Analysis (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Hans‐Georg Lerchen collaborates with scholars based in Germany, France and United States. Hans‐Georg Lerchen's co-authors include Horst Kunz, G. Kempka, Heinz‐Herbert Fiebig, Beatrix Stelte‐Ludwig, Thomas E. Lehmann, Victoria Kolb-Bachofen, Norbert Piel, Simone Greven, Christoph Mahlert and Anette Sommer and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Cancer Research.

In The Last Decade

Hans‐Georg Lerchen

32 papers receiving 414 citations

Peers

Countries citing papers authored by Hans‐Georg Lerchen

Since Specialization

Citations

This map shows the geographic impact of Hans‐Georg Lerchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Georg Lerchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Georg Lerchen more than expected).

Fields of papers citing papers by Hans‐Georg Lerchen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Georg Lerchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Georg Lerchen. The network helps show where Hans‐Georg Lerchen may publish in the future.

Co-authorship network of co-authors of Hans‐Georg Lerchen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Georg Lerchen. A scholar is included among the top collaborators of Hans‐Georg Lerchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Georg Lerchen. Hans‐Georg Lerchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment 2024 ·Frontiers in Pharmacology ·(unknown), Mareike M. Wiedmann, Beatrix Stelte‐Ludwig, Harvey Wong, Amy J. Johnson, Raquel Izumi, Ahmed Hamdy, Hans‐Georg Lerchen	2
2	Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors 2023 ·Cancers ·Hans‐Georg Lerchen, Beatrix Stelte‐Ludwig, Mélanie Héroult, (unknown), Kersten M. Gericke, Harvey Wong, Melanie M. Frigault, Amy J. Johnson, Raquel Izumi, Ahmed Hamdy	8
3	VIP943 Is a Novel CD123 Antibody Drug Conjugate with in Vitro and In Vivo Efficacy in Acute Myeloid Leukemia (AML) Models 2022 ·Blood ·Beatrix Stelte‐Ludwig, (unknown), Tibor Schomber, Melanie M. Frigault, Amy J. Johnson, Hans‐Georg Lerchen, Raquel Izumi, Ahmed Hamdy	1
4	Abstract 4825: Preclinical characterization of BAY-924, a first in class ADC targeting CXCR5-positive B-cell malignancies, with a KSP inhibitor as novel payload 2019 ·Cancer Research ·(unknown), Stefanie Hammer, (unknown), Hans‐Georg Lerchen, Beatrix Stelte‐Ludwig, (unknown), Oliver von Ahsen, Christoph A. Schatz, Simone Greven, Christoph Mahlert, Dominik Mumberg, Pascale Lejeune	1
5	A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy 2019 ·The Journal of Organic Chemistry ·Paul Hoppenz, Sylvia Els‐Heindl, (unknown), Robert Kuhnert, (unknown), Hans‐Georg Lerchen, Johannes Köbberling, Bernd Riedl, Evamarie Hey‐Hawkins, Annette G. Beck‐Sickinger	40
6	Antikörper‐Wirkstoff‐Konjugate mit Pyrrol‐basierten KSP‐Inhibitoren als Payload‐Klasse 2018 ·Angewandte Chemie ·Hans‐Georg Lerchen, (unknown), Beatrix Stelte‐Ludwig, Anette Sommer, Sandra Berndt, Nils Griebenow, (unknown), (unknown), (unknown), Christoph Mahlert, Simone Greven, (unknown)	2
7	Abstract 46: Preclinical activity of novel antibody-drug conjugates with pyrrole-based kinesin spindle protein inhibitors targeting different tumor antigens 2017 ·Cancer Research ·Anette Sommer, Sandra Berndt, Hans‐Georg Lerchen, Beatrix Stelte‐Ludwig, (unknown), (unknown), Lisa Dietz, Christoph Mahlert, Simone Greven, Nils Griebenow, (unknown), Rolf Jautelat, Heiner Apeler, Bertolt Kreft	1
8	Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A₁ Receptor Agonist for the Chronic Treatment of Heart Diseases 2017 ·ChemMedChem ·Daniel Meibom, Barbara Albrecht‐Küpper, Nicole Diedrichs, (unknown), Raimund Kast, Thomas Krämer, (unknown), Hans‐Georg Lerchen, Joachim Mittendorf, Peter G. Nell, (unknown), Alexandros Vakalopoulos, Katja Zimmermann	39
9	Synthetic studies towards bottromycin 2012 ·Beilstein Journal of Organic Chemistry ·(unknown), Hans‐Georg Lerchen, Dieter Häbich, Angelika Ullrich, Uli Kazmaier	16
10	Arginine–pyrimidine conjugates with therapeutic and prophylactic activity in lethal bacterial infections 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dieter Haebich, Hein‐Peter Kroll, Hans‐Georg Lerchen	3
11	Milestones in camptothecin research 2002 ·Drugs of the Future ·Hans‐Georg Lerchen	29
12	Design and Optimization of 20-O-Linked Camptothecin Glycoconjugates as Anticancer Agents 2001 ·Journal of Medicinal Chemistry ·Hans‐Georg Lerchen, (unknown), (unknown), Thomas E. Lehmann, (unknown), G. Kempka, Heinz‐Herbert Fiebig	62
13	Synthesis of 20-O-linked 20(S)-Camptothecin Glycoconjugates: Impact of the Side Chain of the Ester-linked Amino Acid on Epimerization During the Acylation Reaction and on Hydrolytic Stability of the Final Glycoconjugates 2000 ·Journal für praktische Chemie ·Hans‐Georg Lerchen, (unknown)	11
14	Lectin-Mediated Drug Targeting: Discrimination of Carbohydrate-Mediated Cellular Uptake between Tumor and Liver Cells with Neoglycoconjugates Carrying Fucose Epitopes Regioselectively Modified in the 3-Position 1999 ·Angewandte Chemie International Edition ·Hans‐Georg Lerchen, (unknown), Norbert Piel, Victoria Kolb-Bachofen	27
15	Synthesis of Muropeptide Conjugates of 2,3‐Dideoxy‐β‐D‐manno‐2‐octulosonic Acid 1991 ·Angewandte Chemie International Edition in English ·Hans‐Georg Lerchen, Hein‐Peter Kroll	2
16	Synthese von Zellwandpeptidkonjugaten der 2,3‐Didesoxy‐β‐D‐manno‐2‐octulosonsäure 1991 ·Angewandte Chemie ·Hans‐Georg Lerchen, Hein‐Peter Kroll	1
17	Synthesis of Cholecystokinin-Related Peptides and Their Biological Properties 1989 ·Biological Chemistry Hoppe-Seyler ·Erich Wünsch, Luis Moroder, Hans‐Georg Lerchen, Jean Christophe, Michal Svoboda	4
18	Stereoselektive synthese von D-α-hydroxycarbonsäuren bzw. D-α-hydroxycarbonsäuren enthaltenden depsipeptiden aus L-aminosäuren 1985 ·Tetrahedron Letters ·Hans‐Georg Lerchen, Horst Kunz	27
19	Synthesis of the all‐L‐Configurated Cyclohexadepsipeptide cyclo‐[L‐Val‐L‐Lac]₃ by the Peoc/Acid Chloride Method 1984 ·Angewandte Chemie International Edition in English ·Horst Kunz, Hans‐Georg Lerchen	7
20	Synthese des all‐L‐konfigurierten Cyclohexadepsipeptids cyclo‐[L‐Val‐L‐Lac]₃ nach der Peoc/Säurechlorid‐Methode 1984 ·Angewandte Chemie ·Horst Kunz, Hans‐Georg Lerchen	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact